Dow Down 1.20% Nasdaq Down 1.31%

Endocyte, Inc. (ECYT)

-NasdaqGS
5.92 Down 0.16(2.63%) 1:03PM EDT - Nasdaq Real Time Price
Prev Close:6.08
Open:6.10
Bid:5.93 x 700
Ask:5.94 x 4600
1y Target Est:13.11
Beta:0.98
Next Earnings Date: 5-Nov-14ECYT Earnings announcement
Day's Range:5.92 - 6.22
52wk Range:5.91 - 33.70
Volume:1,307,713
Avg Vol (3m):1,320,500
Market Cap:245.98M
P/E (ttm):17.01
EPS (ttm):0.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ECYT

Comparison

Symbol% ChgMkt Cap
ECYTDown 2.63%245.98M
NKTRDown 0.17%1.53B
RHHBYDown 0.18%250.90B
SNSSDown 7.92%397.38M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.09
Quarterly EPS Est (Sep-14) :-0.18
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback